Education: Michigan State University, B.A. in International Relations John Hudson is a reporter at The Washington Post covering the State Department and national security. He was part of the team ...

Instead it was none of these. So too, he says, this mish-mash of livery's. Dr Mark Tronson is a Baptist minister (retired) who served as the Australian cricket team chaplain for 17 years (2000 ret) ...

After hours: January 31 at 4:07:04 PM EST ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

"Witnessing your growth this year has been both an honor and a blessing," Hudson wrote, reposting the image of his new book, "The Art of Winning." "Just when I think you couldn't possibly impress ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

Enter an endless world of play and invention in a limitless recycled playground for children and their grown-ups to tap into their imaginations. Part installation, part adventure playground, REPLAY is ...

But one risk you may not be as familiar with is metabolic dysfunction–associated steatohepatitis (MASH). MASH is a type of liver inflammation and damage caused by a buildup of fat in the liver.